Boyd Watterson Asset Management LLC Abbott Laboratories Transaction History

Boyd Watterson Asset Management LLC

$331 Million
Q3 2025

A detailed history of Boyd Watterson Asset Management LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Boyd Watterson Asset Management LLC holds 19,294 shares of ABT stock, worth $2.51 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares

19,294

Previous 19,573 1.43%

Holding current value

$2.51 Million

Previous $2.66 Million 2.93%

% of portfolio

0.78%

Previous 0.86%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 05, 2025	SELL	$120.51 - $136.62 $33,622 - $38,116	-279 Reduced 1.43%	19,294 $2.58 Million
Q2 2025 Aug 01, 2025	SELL	$123.95 - $138.08 $66,933 - $74,563	-540 Reduced 2.68%	19,573 $2.66 Million
Q1 2025 May 06, 2025	SELL	$111.1 - $140.22 $38,662 - $48,796	-348 Reduced 1.7%	20,113 $2.67 Million
Q3 2024 Oct 22, 2024	SELL	$100.07 - $118.13 $497,247 - $586,987	-4,969 Reduced 19.54%	20,461 $2.33 Million
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $20,448 - $22,825	-203 Reduced 0.79%	25,430 $2.64 Million
Q1 2024 Apr 29, 2024	SELL	$109.52 - $120.96 $15,332 - $16,934	-140 Reduced 0.54%	25,633 $2.91 Million
Q3 2023 Oct 23, 2023	BUY	$95.53 - $114.62 $44,230 - $53,069	463 Added 1.83%	25,773 $2.5 Million
Q1 2023 Apr 19, 2023	SELL	$96.86 - $114.01 $5,811 - $6,840	-60 Reduced 0.24%	25,310 $2.56 Million
Q4 2022 Jan 18, 2023	SELL	$95.06 - $111.52 $3,517 - $4,126	-37 Reduced 0.15%	25,370 $0
Q3 2022 Oct 18, 2022	SELL	$96.76 - $112.03 $967 - $1,120	-10 Reduced 0.04%	25,407 $2.46 Million
Q2 2022 Jul 22, 2022	BUY	$102.07 - $123.37 $13,269 - $16,038	130 Added 0.51%	25,417 $2.76 Million
Q1 2022 Apr 27, 2022	BUY	$114.02 - $139.04 $11,402 - $13,904	100 Added 0.4%	25,287 $2.99 Million
Q4 2021 Jan 26, 2022	SELL	$115.53 - $141.46 $31,193 - $38,194	-270 Reduced 1.06%	25,187 $3.55 Million
Q3 2021 Oct 21, 2021	BUY	$116.66 - $129.06 $21,465 - $23,747	184 Added 0.73%	25,457 $3.01 Million
Q2 2021 Jul 19, 2021	SELL	$105.79 - $124.53 $4,760 - $5,603	-45 Reduced 0.18%	25,273 $2.93 Million
Q1 2021 Apr 27, 2021	SELL	$108.84 - $128.23 $27,210 - $32,057	-250 Reduced 0.98%	25,318 $3.03 Million
Q4 2020 Jan 20, 2021	SELL	$105.0 - $114.42 $341,250 - $371,865	-3,250 Reduced 11.28%	25,568 $2.8 Million
Q3 2020 Oct 23, 2020	BUY	$91.64 - $111.29 $241,013 - $292,692	2,630 Added 10.04%	28,818 $3.14 Million
Q2 2020 Jul 15, 2020	SELL	$76.57 - $98.0 $130,781 - $167,384	-1,708 Reduced 6.12%	26,188 $2.39 Million
Q1 2020 Apr 20, 2020	SELL	$62.82 - $91.86 $7,224 - $10,563	-115 Reduced 0.41%	27,896 $2.2 Million
Q4 2019 Jan 16, 2020	SELL	$78.51 - $87.4 $98,922 - $110,124	-1,260 Reduced 4.3%	28,011 $2.43 Million
Q3 2019 Oct 17, 2019	SELL	$81.84 - $88.74 $89,696 - $97,259	-1,096 Reduced 3.61%	29,271 $2.45 Million
Q2 2019 Jul 24, 2019	SELL	$72.88 - $85.0 $165,729 - $193,290	-2,274 Reduced 6.97%	30,367 $2.55 Million
Q1 2019 Apr 09, 2019	SELL	$66.22 - $80.06 $82,112 - $99,274	-1,240 Reduced 3.66%	32,641 $2.61 Million
Q4 2018 Jan 16, 2019	SELL	$65.56 - $74.27 $295,020 - $334,215	-4,500 Reduced 11.72%	33,881 $2.45 Million
Q3 2018 Oct 17, 2018	SELL	$60.81 - $73.36 $17,513 - $21,127	-288 Reduced 0.74%	38,381 $2.82 Million
Q2 2018 Jul 18, 2018	SELL	$57.57 - $63.54 $132,180 - $145,887	-2,296 Reduced 5.6%	38,669 $2.36 Million
Q1 2018 Apr 19, 2018	SELL	$56.27 - $63.62 $27,459 - $31,046	-488 Reduced 1.18%	40,965 $2.46 Million
Q4 2017 Jan 11, 2018	SELL	$53.68 - $57.47 $50,727 - $54,309	-945 Reduced 2.23%	41,453 $2.37 Million
Q3 2017 Oct 19, 2017	BUY	$48.06 - $53.64 $2.04 Million - $2.27 Million	42,398	42,398 $2.26 Million

Others Institutions Holding ABT

# of Institutions

3,649

Shares Held

1.38B

Call Options Held

10.4M

Put Options Held

9.01M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $228B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boyd Watterson Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boyd Watterson Asset Management LLC with notifications on news.

Account

Boyd Watterson Asset Management LLC Abbott Laboratories Transaction History